一些常见的剂量-暴露-反应估计及其因果识别的条件
Christian Bartels1, Yuchen Wang2, Jonathan French3
1Novartis Pharma AG, Basel, Switzerland.
CPT: pharmacometrics & systems pharmacology
|January 30, 2026
概括
将估计和框架应用于剂量-暴露-反应 (DER) 分析,可以提高药物开发剂量选择. 这种结构化的方法,整合因果推理,提高了DER建模结果的精度和可解释性.
科学领域:
- 制药指标 (Pharmacometrics) 是一个指标.
- 药物开发 药物开发
- 因果推理因果推理
背景情况:
- 暴露-反应 (ER) 分析对于药物开发中的剂量选择至关重要.
- 估计和框架 (ICH E9(R1)) 提供了精确的科学目标定义.
- 标准ER分析往往缺乏与因果推理原则的正式整合.
研究的目的:
- 将估计和框架应用于剂量-暴露-反应 (DER) 分析.
- 通过潜在的结果符号和定向非循环图 (DAG) 形式化剂量反应估计.
- 为了比较DER估计的不同估计策略.
主要方法:
- 使用基于真实世界的场景的模拟研究.
- 估计用潜在结果符号定义和正式化.
- 定向非循环图 (DAG) 表达了研究假设和关系.
- 导出了三种估计方法:聚合的DER,聚合的共变量调整的DR和队列总结.
主要成果:
- 聚合剂量-暴露-反应 (DER) 分析比同变量调整的剂量-反应 (DR) 分析 (较低的平均平方误差) 产生了更精确的估计.
- 综合方法允许在不同的估计方法中正式评估偏差.
- 对于相同的估计,不同的估计方法可以进行比较,以验证.
结论:
- 将估计框架与因果推理整合起来,可以提高DER分析的方法严格性.
- 这种方法提高了建模假设和结果解释的清晰度.
- 这种可概括的策略推进了暴露-反应分析,以精确选择剂量,特别是使用多项研究数据.
相关概念视频
01:03Dose-Response Relationship: Overview
5.1K
Agonists can bind with and activate receptors, resulting in the formation of drug-receptor complexes. Once formed, these complexes catalyze many biochemical processes at the cellular level and subsequently induce a pharmacologic response. The degree of response is directly proportional to the fraction of activated receptors, which in turn, depends on the concentration of the drug at the receptor site as well as the sensitivity of the receptor. An increase in the administered dose contributes to...
5.1K
01:21Causality in Epidemiology
1.6K
Causality or causation is a fundamental concept in epidemiology, vital for understanding the relationships between various factors and health outcomes. Despite its importance, there's no single, universally accepted definition of causality within the discipline. Drawing from a systematic review, causality in epidemiology encompasses several definitions, including production, necessary and sufficient, sufficient-component, counterfactual, and probabilistic models. Each has its strengths and...
1.6K
01:22Dose-Response Relationship: Potency and Efficacy
6.5K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
6.5K
01:25Dose-Response Relationship: Selectivity and Specificity
9.7K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.7K
03:24Common Ion Effect
46.6K
Compared with pure water, the solubility of an ionic compound is less in aqueous solutions containing a common ion (one also produced by dissolution of the ionic compound). This is an example of a phenomenon known as the common ion effect, which is a consequence of the law of mass action that may be explained using Le Châtelier’s principle. Consider the dissolution of silver iodide:
46.6K
01:21Dose Size and Dosing Frequency: Determination Methods
291
Determining the optimal dose size and dosing frequency in pharmacotherapy is crucial for achieving therapeutic effectiveness while minimizing adverse effects. This article explores the methodologies employed in determining these parameters, focusing on their significance and interplay to tailor dosing regimens.Dose Size: Dose size refers to the amount of a drug administered in a single dose. It is determined based on the drug's pharmacodynamics and pharmacokinetics properties and...
291